2m 2m 2m 2m 2m 2m 2m
TREVI THERAPEUTI (TRVI)
NASDAQ
$17.36-$0.36 (-2.00%)
Price as of Jun 23, 2026 7:16 PM EDT- $2.5BMarket Cap
- 208.00%1-Year Change
- BiotechnologyIndustry
TREVI THERAPEUTI (TRVI)
$17.36-$0.36 (-2.00%)
TRVI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.71 | ||
Change | +$0.50 (+2.91%) | ||
Open | $17.41 | ||
High | $18.11 | ||
Low | $17.16 | ||
Previous Close | $17.21 | ||
Volume | 2,461,136 | ||
30-Day Average Volume | 1,375,900 | ||
1-Week Change | 20.80% | ||
1-Month Change | 25.34% | ||
1-Year Change | 208.00% | ||
3-Year Change | 541.67% | ||
5-Year Change | 763.90% | ||
Fundamentals | |||
Shares Outstanding | 142.0M | ||
Total Assets | $179.6M | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.5B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$13.2M | ||
Free Cash Flow | -$16.8M | ||
EBIT | -$13.2M | ||
EBITDA | -$13.2M | ||
Net Working Capital | $169.0M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | -189 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 15 | ||
P/E | -197 | ||
PEG | 3 | ||
Price/Free Cash Flow | -150 | ||
Price/Operating Cash Flow | -151 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue